Index by author

September 01, 2001; Volume 28,Issue 9

A

  1. Abdul-Karim, F W

    1. Treatment of collagen induced arthritis by proteolytic enzymes: immunomodulatory and disease modifying effects.
      S R Chintalacharuvu, N Urankar-Nagy, C A Petersilge, F W Abdul-Karim and S N Emancipator
      The Journal of Rheumatology September 1 2001, 28 (9) 2049-2059;

  2. Akisue, T

    1. Osteoarthropathy associated with Weber-Christian disease.
      T Yamamoto, K Nagira, T Akisue and M Kurosaka
      The Journal of Rheumatology September 1 2001, 28 (9) 2136-2138;

  3. Aleksza, M

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  4. Antal-Szamás, P

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  5. Arroyo, F

    1. Carpal collapse in rheumatoid arthritis--prevalence and clinical significance: a preliminary study.
      L Daza, F Arroyo, J Dozal and J Morales
      The Journal of Rheumatology September 1 2001, 28 (9) 1975-1978;

  6. Artacker, G

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

B

  1. Bartosh, S

    1. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
      S Buratti, I S Szer, C H Spencer, S Bartosh and A Reiff
      The Journal of Rheumatology September 1 2001, 28 (9) 2103-2108;

  2. Bates, D W

    1. Referrals for musculoskeletal disorders: patterns, predictors, and outcomes.
      D H Solomon, D W Bates, J L Schaffer, J Horsky, E Burdick and J N Katz
      The Journal of Rheumatology September 1 2001, 28 (9) 2090-2095;

  3. Bergin, D

    1. Power Doppler ultrasound assessment of rheumatoid hand synovitis.
      M Stone, D Bergin, B Whelan, M Maher, J Murray and C McCarthy
      The Journal of Rheumatology September 1 2001, 28 (9) 1979-1982;

  4. Bernecker, M

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

  5. Bieber, T

    1. Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis.
      J Wenzel and T Bieber
      The Journal of Rheumatology September 1 2001, 28 (9) 2139;

  6. Bijlsma, J W

    1. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
      C M Verhoef, J A van Roon, M E Vianen, J W Bijlsma and F P Lafeber
      The Journal of Rheumatology September 1 2001, 28 (9) 1960-1966;

  7. Bletry, O

    1. A study of 75 pregnancies in patients with antiphospholipid syndrome.
      D L Huong, B Wechsler, O Bletry, D Vauthier-Brouzes, G Lefebvre and J C Piette
      The Journal of Rheumatology September 1 2001, 28 (9) 2025-2030;

  8. Bove, K E

    1. Etanercept in the treatment of macrophage activation syndrome.
      S Prahalad, K E Bove, D Dickens, D J Lovell and A A Grom
      The Journal of Rheumatology September 1 2001, 28 (9) 2120-2124;

  9. Breedveld, F

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  10. Buratti, S

    1. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
      S Buratti, I S Szer, C H Spencer, S Bartosh and A Reiff
      The Journal of Rheumatology September 1 2001, 28 (9) 2103-2108;

  11. Burdick, E

    1. Referrals for musculoskeletal disorders: patterns, predictors, and outcomes.
      D H Solomon, D W Bates, J L Schaffer, J Horsky, E Burdick and J N Katz
      The Journal of Rheumatology September 1 2001, 28 (9) 2090-2095;

C

  1. Callen, J P

    1. Calcifying lupus panniculitis in a patient with subacute cutaneous lupus erythematosus: response to diltiazem and chloroquine.
      K W Morgan and J P Callen
      The Journal of Rheumatology September 1 2001, 28 (9) 2129-2132;

  2. Campos, G B

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

  3. Chintalacharuvu, S R

    1. Treatment of collagen induced arthritis by proteolytic enzymes: immunomodulatory and disease modifying effects.
      S R Chintalacharuvu, N Urankar-Nagy, C A Petersilge, F W Abdul-Karim and S N Emancipator
      The Journal of Rheumatology September 1 2001, 28 (9) 2049-2059;

  4. Clark, C A

    1. The spectrum of the antiphospholipid syndrome: a matter of perspective.
      C A Clark, K A Spitzer and C A Laskin
      The Journal of Rheumatology September 1 2001, 28 (9) 1939-1941;

  5. Colantuoni, G

    1. Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites.
      M Quintero, G Colantuoni, A M Khatib, A Panasyuk, A Lomri and D R Mitrovic
      The Journal of Rheumatology September 1 2001, 28 (9) 2075-2084;

  6. Crivellari, H

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

  7. Cruz, B A

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

D

  1. Daly, J

    1. Disease status predicts fatigue in systemic lupus erythematosus.
      W G Tayer, P M Nicassio, M H Weisman, C Schuman and J Daly
      The Journal of Rheumatology September 1 2001, 28 (9) 1999-2007;

  2. Damasceno, R P

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

  3. Daza, L

    1. Carpal collapse in rheumatoid arthritis--prevalence and clinical significance: a preliminary study.
      L Daza, F Arroyo, J Dozal and J Morales
      The Journal of Rheumatology September 1 2001, 28 (9) 1975-1978;

  4. Desaulniers, N

    1. Different levels of COX-1 and COX-2 enzymes in synoviocytes and chondrocytes during joint contracture formation.
      G Trudel, N Desaulniers, H K Uhthoff and O Laneuville
      The Journal of Rheumatology September 1 2001, 28 (9) 2066-2074;

  5. Dickens, D

    1. Etanercept in the treatment of macrophage activation syndrome.
      S Prahalad, K E Bove, D Dickens, D J Lovell and A A Grom
      The Journal of Rheumatology September 1 2001, 28 (9) 2120-2124;

  6. Dijkmans, B

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  7. Doran, M F

    1. Infections in rheumatoid arthritis--a new phenomenon?
      M F Doran and S E Gabriel
      The Journal of Rheumatology September 1 2001, 28 (9) 1942-1943;

  8. Dorner, T

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

  9. Dozal, J

    1. Carpal collapse in rheumatoid arthritis--prevalence and clinical significance: a preliminary study.
      L Daza, F Arroyo, J Dozal and J Morales
      The Journal of Rheumatology September 1 2001, 28 (9) 1975-1978;

E

  1. Emancipator, S N

    1. Treatment of collagen induced arthritis by proteolytic enzymes: immunomodulatory and disease modifying effects.
      S R Chintalacharuvu, N Urankar-Nagy, C A Petersilge, F W Abdul-Karim and S N Emancipator
      The Journal of Rheumatology September 1 2001, 28 (9) 2049-2059;

F

  1. Falger, J

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

  2. Ferrari, R

    1. Physician resistance to the late whiplash syndrome.
      S N Virani, R Ferrari and A S Russell
      The Journal of Rheumatology September 1 2001, 28 (9) 2096-2099;

  3. Fujiwara, H

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

G

  1. Gabriel, S E

    1. Infections in rheumatoid arthritis--a new phenomenon?
      M F Doran and S E Gabriel
      The Journal of Rheumatology September 1 2001, 28 (9) 1942-1943;

  2. García-Porrúa, C

    1. Endocarditis in adult onset Still's disease: a 12 month followup.
      C García-Porrúa, C González-Juanatey and M A González-Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2141-2142;
    2. Idiopathic lateral sinus thrombosis mimicking giant cell arteritis.
      C García-Porrúa, J Vega Andión and M A González-Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2142-2143;

  3. Gay, R E

    1. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
      R E Gay, M Neidhart, F Pataky, S Tries, S Laufer and S Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2060-2065;

  4. Gay, S

    1. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
      R E Gay, M Neidhart, F Pataky, S Tries, S Laufer and S Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2060-2065;

  5. Gergely, P

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  6. González-Gay, M A

    1. Endocarditis in adult onset Still's disease: a 12 month followup.
      C García-Porrúa, C González-Juanatey and M A González-Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2141-2142;
    2. Idiopathic lateral sinus thrombosis mimicking giant cell arteritis.
      C García-Porrúa, J Vega Andión and M A González-Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2142-2143;

  7. González-Juanatey, C

    1. Endocarditis in adult onset Still's disease: a 12 month followup.
      C García-Porrúa, C González-Juanatey and M A González-Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2141-2142;

  8. Greenwald, R

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  9. Grom, A A

    1. Etanercept in the treatment of macrophage activation syndrome.
      S Prahalad, K E Bove, D Dickens, D J Lovell and A A Grom
      The Journal of Rheumatology September 1 2001, 28 (9) 2120-2124;

H

  1. Haller, H

    1. Nephrotoxicity of selective COX-2 inhibitors.
      A Woywodt, A Schwarz, M Mengel, H Haller, H Zeidler and L Köhler
      The Journal of Rheumatology September 1 2001, 28 (9) 2133-2135;

  2. Hanly, J G

    1. Manpower in Canadian academic rheumatology units: current status and future trends. Canadian Council of Academic Rheumatologists.
      J G Hanly and Canadian Council of Academic Rheumatologists
      The Journal of Rheumatology September 1 2001, 28 (9) 1944-1951;

  3. Hansen, K E

    1. Risk factors associated with thrombosis in patients with antiphospholipid antibodies.
      K E Hansen, D F Kong, K D Moore and T L Ortel
      The Journal of Rheumatology September 1 2001, 28 (9) 2018-2024;

  4. Haugen, M

    1. Health status in fibromyalgia--a followup study.
      A M Mengshoel and M Haugen
      The Journal of Rheumatology September 1 2001, 28 (9) 2085-2089;

  5. Herlin, T

    1. Resorption of the temporomandibular condylar bone according to subtypes of juvenile chronic arthritis.
      T K Pedersen, J J Jensen, B Melsen and T Herlin
      The Journal of Rheumatology September 1 2001, 28 (9) 2109-2115;

  6. Hess, E

    1. In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
      A B Mongey and E Hess
      The Journal of Rheumatology September 1 2001, 28 (9) 1992-1998;

  7. Horsky, J

    1. Referrals for musculoskeletal disorders: patterns, predictors, and outcomes.
      D H Solomon, D W Bates, J L Schaffer, J Horsky, E Burdick and J N Katz
      The Journal of Rheumatology September 1 2001, 28 (9) 2090-2095;

  8. Huemer, C

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

  9. Huemer, M

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

  10. Huong, D L

    1. A study of 75 pregnancies in patients with antiphospholipid syndrome.
      D L Huong, B Wechsler, O Bletry, D Vauthier-Brouzes, G Lefebvre and J C Piette
      The Journal of Rheumatology September 1 2001, 28 (9) 2025-2030;

I

  1. Illés, A

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

J

  1. Jensen, J J

    1. Resorption of the temporomandibular condylar bone according to subtypes of juvenile chronic arthritis.
      T K Pedersen, J J Jensen, B Melsen and T Herlin
      The Journal of Rheumatology September 1 2001, 28 (9) 2109-2115;

  2. Ji, J D

    1. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2008-2011;

  3. Jones, P

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

K

  1. Kalden, J R

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  2. Katz, J N

    1. Referrals for musculoskeletal disorders: patterns, predictors, and outcomes.
      D H Solomon, D W Bates, J L Schaffer, J Horsky, E Burdick and J N Katz
      The Journal of Rheumatology September 1 2001, 28 (9) 2090-2095;

  3. Khatib, A M

    1. Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites.
      M Quintero, G Colantuoni, A M Khatib, A Panasyuk, A Lomri and D R Mitrovic
      The Journal of Rheumatology September 1 2001, 28 (9) 2075-2084;

  4. Kim, H A

    1. Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage.
      H A Kim, D I Suh and Y W Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2038-2045;

  5. Kim, Y R

    1. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2008-2011;

  6. Kishimoto, T

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

  7. Kiss, E

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  8. Köhler, L

    1. Nephrotoxicity of selective COX-2 inhibitors.
      A Woywodt, A Schwarz, M Mengel, H Haller, H Zeidler and L Köhler
      The Journal of Rheumatology September 1 2001, 28 (9) 2133-2135;

  9. Kong, D F

    1. Risk factors associated with thrombosis in patients with antiphospholipid antibodies.
      K E Hansen, D F Kong, K D Moore and T L Ortel
      The Journal of Rheumatology September 1 2001, 28 (9) 2018-2024;

  10. Konica, K

    1. The role of colchicine in Helicobacter pylori prevalence and gastric mucosal changes in Behçet's Disease.
      C Pata, K Konica and A Yazar
      The Journal of Rheumatology September 1 2001, 28 (9) 2144;

  11. Kovács, I

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  12. Kurosaka, M

    1. Osteoarthropathy associated with Weber-Christian disease.
      T Yamamoto, K Nagira, T Akisue and M Kurosaka
      The Journal of Rheumatology September 1 2001, 28 (9) 2136-2138;

  13. Kvien, T K

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

L

  1. Lafeber, F P

    1. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
      C M Verhoef, J A van Roon, M E Vianen, J W Bijlsma and F P Lafeber
      The Journal of Rheumatology September 1 2001, 28 (9) 1960-1966;

  2. Lakos, G

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  3. Laneuville, O

    1. Different levels of COX-1 and COX-2 enzymes in synoviocytes and chondrocytes during joint contracture formation.
      G Trudel, N Desaulniers, H K Uhthoff and O Laneuville
      The Journal of Rheumatology September 1 2001, 28 (9) 2066-2074;

  4. Laskin, C A

    1. The spectrum of the antiphospholipid syndrome: a matter of perspective.
      C A Clark, K A Spitzer and C A Laskin
      The Journal of Rheumatology September 1 2001, 28 (9) 1939-1941;

  5. Laufer, S

    1. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
      R E Gay, M Neidhart, F Pataky, S Tries, S Laufer and S Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2060-2065;

  6. Lee, Y H

    1. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2008-2011;

  7. Lefebvre, G

    1. A study of 75 pregnancies in patients with antiphospholipid syndrome.
      D L Huong, B Wechsler, O Bletry, D Vauthier-Brouzes, G Lefebvre and J C Piette
      The Journal of Rheumatology September 1 2001, 28 (9) 2025-2030;

  8. Lomri, A

    1. Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites.
      M Quintero, G Colantuoni, A M Khatib, A Panasyuk, A Lomri and D R Mitrovic
      The Journal of Rheumatology September 1 2001, 28 (9) 2075-2084;

  9. Lovell, D J

    1. Etanercept in the treatment of macrophage activation syndrome.
      S Prahalad, K E Bove, D Dickens, D J Lovell and A A Grom
      The Journal of Rheumatology September 1 2001, 28 (9) 2120-2124;

M

  1. Maher, M

    1. Power Doppler ultrasound assessment of rheumatoid hand synovitis.
      M Stone, D Bergin, B Whelan, M Maher, J Murray and C McCarthy
      The Journal of Rheumatology September 1 2001, 28 (9) 1979-1982;

  2. Manzoni, S M

    1. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
      A Ravelli, S M Manzoni, S Viola, A Pistorio, N Ruperto and A Martini
      The Journal of Rheumatology September 1 2001, 28 (9) 2100-2102;

  3. Martini, A

    1. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
      A Ravelli, S M Manzoni, S Viola, A Pistorio, N Ruperto and A Martini
      The Journal of Rheumatology September 1 2001, 28 (9) 2100-2102;

  4. McCarthy, C

    1. Power Doppler ultrasound assessment of rheumatoid hand synovitis.
      M Stone, D Bergin, B Whelan, M Maher, J Murray and C McCarthy
      The Journal of Rheumatology September 1 2001, 28 (9) 1979-1982;

  5. Melsen, B

    1. Resorption of the temporomandibular condylar bone according to subtypes of juvenile chronic arthritis.
      T K Pedersen, J J Jensen, B Melsen and T Herlin
      The Journal of Rheumatology September 1 2001, 28 (9) 2109-2115;

  6. Mengel, M

    1. Nephrotoxicity of selective COX-2 inhibitors.
      A Woywodt, A Schwarz, M Mengel, H Haller, H Zeidler and L Köhler
      The Journal of Rheumatology September 1 2001, 28 (9) 2133-2135;

  7. Mengshoel, A M

    1. Health status in fibromyalgia--a followup study.
      A M Mengshoel and M Haugen
      The Journal of Rheumatology September 1 2001, 28 (9) 2085-2089;

  8. Mitrovic, D R

    1. Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites.
      M Quintero, G Colantuoni, A M Khatib, A Panasyuk, A Lomri and D R Mitrovic
      The Journal of Rheumatology September 1 2001, 28 (9) 2075-2084;

  9. Molenaar, E

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  10. Mongey, A B

    1. In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
      A B Mongey and E Hess
      The Journal of Rheumatology September 1 2001, 28 (9) 1992-1998;

  11. Moore, K D

    1. Risk factors associated with thrombosis in patients with antiphospholipid antibodies.
      K E Hansen, D F Kong, K D Moore and T L Ortel
      The Journal of Rheumatology September 1 2001, 28 (9) 2018-2024;

  12. Morales, J

    1. Carpal collapse in rheumatoid arthritis--prevalence and clinical significance: a preliminary study.
      L Daza, F Arroyo, J Dozal and J Morales
      The Journal of Rheumatology September 1 2001, 28 (9) 1975-1978;

  13. Morgan, K W

    1. Calcifying lupus panniculitis in a patient with subacute cutaneous lupus erythematosus: response to diltiazem and chloroquine.
      K W Morgan and J P Callen
      The Journal of Rheumatology September 1 2001, 28 (9) 2129-2132;

  14. Murata, N

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

  15. Murray, J

    1. Power Doppler ultrasound assessment of rheumatoid hand synovitis.
      M Stone, D Bergin, B Whelan, M Maher, J Murray and C McCarthy
      The Journal of Rheumatology September 1 2001, 28 (9) 1979-1982;

  16. Murray, K J

    1. Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy.
      K Nistala and K J Murray
      The Journal of Rheumatology September 1 2001, 28 (9) 2125-2128;

N

  1. Nagira, K

    1. Osteoarthropathy associated with Weber-Christian disease.
      T Yamamoto, K Nagira, T Akisue and M Kurosaka
      The Journal of Rheumatology September 1 2001, 28 (9) 2136-2138;

  2. Narazaki, M

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

  3. Neidhart, M

    1. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
      R E Gay, M Neidhart, F Pataky, S Tries, S Laufer and S Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2060-2065;

  4. Nesher, G

    1. Visual hallucinations in giant cell arteritis: association with visual loss.
      G Nesher, R Nesher, Y Rozenman and M Sonnenblick
      The Journal of Rheumatology September 1 2001, 28 (9) 2046-2048;

  5. Nesher, R

    1. Visual hallucinations in giant cell arteritis: association with visual loss.
      G Nesher, R Nesher, Y Rozenman and M Sonnenblick
      The Journal of Rheumatology September 1 2001, 28 (9) 2046-2048;

  6. Nicassio, P M

    1. Disease status predicts fatigue in systemic lupus erythematosus.
      W G Tayer, P M Nicassio, M H Weisman, C Schuman and J Daly
      The Journal of Rheumatology September 1 2001, 28 (9) 1999-2007;

  7. Nietert, P J

    1. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.
      P J Nietert, M D Silverstein and R M Silver
      The Journal of Rheumatology September 1 2001, 28 (9) 2031-2037;

  8. Nistala, K

    1. Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy.
      K Nistala and K J Murray
      The Journal of Rheumatology September 1 2001, 28 (9) 2125-2128;

  9. Noël, B

    1. Occupational factors in systemic sclerosis.
      B Noël
      The Journal of Rheumatology September 1 2001, 28 (9) 2139-2140;

  10. Nunes, S V

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

O

  1. Oed, C

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  2. Ortel, T L

    1. Risk factors associated with thrombosis in patients with antiphospholipid antibodies.
      K E Hansen, D F Kong, K D Moore and T L Ortel
      The Journal of Rheumatology September 1 2001, 28 (9) 2018-2024;

P

  1. Panasyuk, A

    1. Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites.
      M Quintero, G Colantuoni, A M Khatib, A Panasyuk, A Lomri and D R Mitrovic
      The Journal of Rheumatology September 1 2001, 28 (9) 2075-2084;

  2. Pata, C

    1. The role of colchicine in Helicobacter pylori prevalence and gastric mucosal changes in Behçet's Disease.
      C Pata, K Konica and A Yazar
      The Journal of Rheumatology September 1 2001, 28 (9) 2144;

  3. Pataky, F

    1. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
      R E Gay, M Neidhart, F Pataky, S Tries, S Laufer and S Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2060-2065;

  4. Pedersen, T K

    1. Resorption of the temporomandibular condylar bone according to subtypes of juvenile chronic arthritis.
      T K Pedersen, J J Jensen, B Melsen and T Herlin
      The Journal of Rheumatology September 1 2001, 28 (9) 2109-2115;

  5. Petersilge, C A

    1. Treatment of collagen induced arthritis by proteolytic enzymes: immunomodulatory and disease modifying effects.
      S R Chintalacharuvu, N Urankar-Nagy, C A Petersilge, F W Abdul-Karim and S N Emancipator
      The Journal of Rheumatology September 1 2001, 28 (9) 2049-2059;

  6. Piette, J C

    1. A study of 75 pregnancies in patients with antiphospholipid syndrome.
      D L Huong, B Wechsler, O Bletry, D Vauthier-Brouzes, G Lefebvre and J C Piette
      The Journal of Rheumatology September 1 2001, 28 (9) 2025-2030;

  7. Pilz, I

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

  8. Pistorio, A

    1. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
      A Ravelli, S M Manzoni, S Viola, A Pistorio, N Ruperto and A Martini
      The Journal of Rheumatology September 1 2001, 28 (9) 2100-2102;

  9. Prahalad, S

    1. Etanercept in the treatment of macrophage activation syndrome.
      S Prahalad, K E Bove, D Dickens, D J Lovell and A A Grom
      The Journal of Rheumatology September 1 2001, 28 (9) 2120-2124;

Q

  1. Quintero, M

    1. Granulocyte-macrophage colony stimulating factor activates proteoglycan, type II collagen, and cAMP production by rat articular chondrocytes through specific binding sites.
      M Quintero, G Colantuoni, A M Khatib, A Panasyuk, A Lomri and D R Mitrovic
      The Journal of Rheumatology September 1 2001, 28 (9) 2075-2084;

R

  1. Ravelli, A

    1. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
      A Ravelli, S M Manzoni, S Viola, A Pistorio, N Ruperto and A Martini
      The Journal of Rheumatology September 1 2001, 28 (9) 2100-2102;

  2. Reiff, A

    1. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
      S Buratti, I S Szer, C H Spencer, S Bartosh and A Reiff
      The Journal of Rheumatology September 1 2001, 28 (9) 2103-2108;

  3. Ribeiro, L S

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

  4. Ronday, K

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  5. Rosenburg, R

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  6. Rozenman, Y

    1. Visual hallucinations in giant cell arteritis: association with visual loss.
      G Nesher, R Nesher, Y Rozenman and M Sonnenblick
      The Journal of Rheumatology September 1 2001, 28 (9) 2046-2048;

  7. Rozman, B

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  8. Ruperto, N

    1. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
      A Ravelli, S M Manzoni, S Viola, A Pistorio, N Ruperto and A Martini
      The Journal of Rheumatology September 1 2001, 28 (9) 2100-2102;

  9. Russell, A S

    1. Physician resistance to the late whiplash syndrome.
      S N Virani, R Ferrari and A S Russell
      The Journal of Rheumatology September 1 2001, 28 (9) 2096-2099;

S

  1. Santos, L A

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

  2. Schacherl, H

    1. Incidence of pediatric rheumatic diseases in a regional population in Austria.
      C Huemer, M Huemer, T Dorner, J Falger, H Schacherl, M Bernecker, G Artacker and I Pilz
      The Journal of Rheumatology September 1 2001, 28 (9) 2116-2119;

  3. Schaffer, J L

    1. Referrals for musculoskeletal disorders: patterns, predictors, and outcomes.
      D H Solomon, D W Bates, J L Schaffer, J Horsky, E Burdick and J N Katz
      The Journal of Rheumatology September 1 2001, 28 (9) 2090-2095;

  4. Schattenkirchner, M

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  5. Schuman, C

    1. Disease status predicts fatigue in systemic lupus erythematosus.
      W G Tayer, P M Nicassio, M H Weisman, C Schuman and J Daly
      The Journal of Rheumatology September 1 2001, 28 (9) 1999-2007;

  6. Schwarz, A

    1. Nephrotoxicity of selective COX-2 inhibitors.
      A Woywodt, A Schwarz, M Mengel, H Haller, H Zeidler and L Köhler
      The Journal of Rheumatology September 1 2001, 28 (9) 2133-2135;

  7. Scott, D L

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  8. Shima, Y

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

  9. Silver, R M

    1. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.
      P J Nietert, M D Silverstein and R M Silver
      The Journal of Rheumatology September 1 2001, 28 (9) 2031-2037;

  10. Silverstein, M D

    1. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.
      P J Nietert, M D Silverstein and R M Silver
      The Journal of Rheumatology September 1 2001, 28 (9) 2031-2037;

  11. Sipka, S

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  12. Smolen, J S

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  13. Sohn, J

    1. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2008-2011;

  14. Solomon, D H

    1. Referrals for musculoskeletal disorders: patterns, predictors, and outcomes.
      D H Solomon, D W Bates, J L Schaffer, J Horsky, E Burdick and J N Katz
      The Journal of Rheumatology September 1 2001, 28 (9) 2090-2095;

  15. Song, G G

    1. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
      Y H Lee, Y R Kim, J D Ji, J Sohn and G G Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2008-2011;

  16. Song, Y W

    1. Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage.
      H A Kim, D I Suh and Y W Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2038-2045;

  17. Sonnenblick, M

    1. Visual hallucinations in giant cell arteritis: association with visual loss.
      G Nesher, R Nesher, Y Rozenman and M Sonnenblick
      The Journal of Rheumatology September 1 2001, 28 (9) 2046-2048;

  18. Spencer, C H

    1. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
      S Buratti, I S Szer, C H Spencer, S Bartosh and A Reiff
      The Journal of Rheumatology September 1 2001, 28 (9) 2103-2108;

  19. Spitzer, K A

    1. The spectrum of the antiphospholipid syndrome: a matter of perspective.
      C A Clark, K A Spitzer and C A Laskin
      The Journal of Rheumatology September 1 2001, 28 (9) 1939-1941;

  20. Stone, M

    1. Power Doppler ultrasound assessment of rheumatoid hand synovitis.
      M Stone, D Bergin, B Whelan, M Maher, J Murray and C McCarthy
      The Journal of Rheumatology September 1 2001, 28 (9) 1979-1982;

  21. Suemura, M

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

  22. Suh, D I

    1. Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage.
      H A Kim, D I Suh and Y W Song
      The Journal of Rheumatology September 1 2001, 28 (9) 2038-2045;

  23. Szántó, S

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  24. Szegedi, G

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

  25. Szer, I S

    1. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
      S Buratti, I S Szer, C H Spencer, S Bartosh and A Reiff
      The Journal of Rheumatology September 1 2001, 28 (9) 2103-2108;

  26. Szucs, K

    1. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
      S Sipka, S Szántó, K Szucs, I Kovács, E Kiss, P Antal-Szamás, G Lakos, M Aleksza, A Illés, P Gergely and G Szegedi
      The Journal of Rheumatology September 1 2001, 28 (9) 2012-2017;

T

  1. Tanaka, T

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

  2. Tayer, W G

    1. Disease status predicts fatigue in systemic lupus erythematosus.
      W G Tayer, P M Nicassio, M H Weisman, C Schuman and J Daly
      The Journal of Rheumatology September 1 2001, 28 (9) 1999-2007;

  3. TeKoppele, J

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  4. Tries, S

    1. Dual inhibition of 5-lipoxygenase and cyclooxygenases 1 and 2 by ML3000 reduces joint destruction in adjuvant arthritis.
      R E Gay, M Neidhart, F Pataky, S Tries, S Laufer and S Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2060-2065;

  5. Trudel, G

    1. Different levels of COX-1 and COX-2 enzymes in synoviocytes and chondrocytes during joint contracture formation.
      G Trudel, N Desaulniers, H K Uhthoff and O Laneuville
      The Journal of Rheumatology September 1 2001, 28 (9) 2066-2074;

  6. Tsuyuguchi, I

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

U

  1. Uhthoff, H K

    1. Different levels of COX-1 and COX-2 enzymes in synoviocytes and chondrocytes during joint contracture formation.
      G Trudel, N Desaulniers, H K Uhthoff and O Laneuville
      The Journal of Rheumatology September 1 2001, 28 (9) 2066-2074;

  2. Urankar-Nagy, N

    1. Treatment of collagen induced arthritis by proteolytic enzymes: immunomodulatory and disease modifying effects.
      S R Chintalacharuvu, N Urankar-Nagy, C A Petersilge, F W Abdul-Karim and S N Emancipator
      The Journal of Rheumatology September 1 2001, 28 (9) 2049-2059;

V

  1. van der Laan, W

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  2. van Roon, J A

    1. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
      C M Verhoef, J A van Roon, M E Vianen, J W Bijlsma and F P Lafeber
      The Journal of Rheumatology September 1 2001, 28 (9) 1960-1966;

  3. Vauthier-Brouzes, D

    1. A study of 75 pregnancies in patients with antiphospholipid syndrome.
      D L Huong, B Wechsler, O Bletry, D Vauthier-Brouzes, G Lefebvre and J C Piette
      The Journal of Rheumatology September 1 2001, 28 (9) 2025-2030;

  4. Vega Andión, J

    1. Idiopathic lateral sinus thrombosis mimicking giant cell arteritis.
      C García-Porrúa, J Vega Andión and M A González-Gay
      The Journal of Rheumatology September 1 2001, 28 (9) 2142-2143;

  5. Verheijen, J

    1. Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.
      W van der Laan, E Molenaar, K Ronday, J Verheijen, F Breedveld, R Greenwald, B Dijkmans and J TeKoppele
      The Journal of Rheumatology September 1 2001, 28 (9) 1967-1974;

  6. Verhoef, C M

    1. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
      C M Verhoef, J A van Roon, M E Vianen, J W Bijlsma and F P Lafeber
      The Journal of Rheumatology September 1 2001, 28 (9) 1960-1966;

  7. Vianen, M E

    1. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
      C M Verhoef, J A van Roon, M E Vianen, J W Bijlsma and F P Lafeber
      The Journal of Rheumatology September 1 2001, 28 (9) 1960-1966;

  8. Viola, S

    1. Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis.
      A Ravelli, S M Manzoni, S Viola, A Pistorio, N Ruperto and A Martini
      The Journal of Rheumatology September 1 2001, 28 (9) 2100-2102;

  9. Virani, S N

    1. Physician resistance to the late whiplash syndrome.
      S N Virani, R Ferrari and A S Russell
      The Journal of Rheumatology September 1 2001, 28 (9) 2096-2099;

W

  1. Wechsler, B

    1. A study of 75 pregnancies in patients with antiphospholipid syndrome.
      D L Huong, B Wechsler, O Bletry, D Vauthier-Brouzes, G Lefebvre and J C Piette
      The Journal of Rheumatology September 1 2001, 28 (9) 2025-2030;

  2. Weisman, M H

    1. Disease status predicts fatigue in systemic lupus erythematosus.
      W G Tayer, P M Nicassio, M H Weisman, C Schuman and J Daly
      The Journal of Rheumatology September 1 2001, 28 (9) 1999-2007;

  3. Wenzel, J

    1. Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis.
      J Wenzel and T Bieber
      The Journal of Rheumatology September 1 2001, 28 (9) 2139;

  4. Whelan, B

    1. Power Doppler ultrasound assessment of rheumatoid hand synovitis.
      M Stone, D Bergin, B Whelan, M Maher, J Murray and C McCarthy
      The Journal of Rheumatology September 1 2001, 28 (9) 1979-1982;

  5. Williams, B D

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  6. Williams, R B

    1. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
      J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
      The Journal of Rheumatology September 1 2001, 28 (9) 1983-1991;

  7. Woywodt, A

    1. Nephrotoxicity of selective COX-2 inhibitors.
      A Woywodt, A Schwarz, M Mengel, H Haller, H Zeidler and L Köhler
      The Journal of Rheumatology September 1 2001, 28 (9) 2133-2135;

X

  1. Xavier, G A

    1. Dural sinus thrombosis in childhood systemic lupus erythematosus.
      B A Cruz, L A Santos, R P Damasceno, L S Ribeiro, G A Xavier Jr, S V Nunes, G B Campos and H Crivellari
      The Journal of Rheumatology September 1 2001, 28 (9) 2140-2141;

Y

  1. Yamamoto, T

    1. Osteoarthropathy associated with Weber-Christian disease.
      T Yamamoto, K Nagira, T Akisue and M Kurosaka
      The Journal of Rheumatology September 1 2001, 28 (9) 2136-2138;

  2. Yazar, A

    1. The role of colchicine in Helicobacter pylori prevalence and gastric mucosal changes in Behçet's Disease.
      C Pata, K Konica and A Yazar
      The Journal of Rheumatology September 1 2001, 28 (9) 2144;

  3. Yokota, A

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

  4. Yoshizaki, K

    1. Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells.
      A Yokota, M Narazaki, Y Shima, N Murata, T Tanaka, M Suemura, K Yoshizaki, H Fujiwara, I Tsuyuguchi and T Kishimoto
      The Journal of Rheumatology September 1 2001, 28 (9) 1952-1959;

Z

  1. Zeidler, H

    1. Nephrotoxicity of selective COX-2 inhibitors.
      A Woywodt, A Schwarz, M Mengel, H Haller, H Zeidler and L Köhler
      The Journal of Rheumatology September 1 2001, 28 (9) 2133-2135;
Back to top

In this issue